Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kamyar Afarinkia is active.

Publication


Featured researches published by Kamyar Afarinkia.


Tetrahedron | 1990

Synthesis of organophosphorus compounds via silyl esters of phosphorous acids

Kamyar Afarinkia; Charles W. Rees; J. I. G. Cadogan

Abstract The addition of trimethylsilyloxy phosphorus (III)derivatives generated in situ to imines at room temperature provides a mild selective and high yielding route to α-aminoalkylphosphorate and α-aminoalkylphenylphosphinate esters. Isocyanates and carbodiimides react similarly to give phosphonoureas and phosphonoguarnidines respectively aldehydes and ketones are much less reactive and cyanides are inert.


Future Medicinal Chemistry | 2012

A beginner’s guide to chemokines

Victoria Vinader; Kamyar Afarinkia

This review provides an overview of chemokines and their receptors, with an emphasis on general features and nomenclature along with a short summary of their properties and functions. It is intended as an introduction to the subject and a reference point for those wishing to learn key facts about chemokines and their role in biology.


Future Medicinal Chemistry | 2012

The emerging role of CXC chemokines and their receptors in cancer.

Vinader; Kamyar Afarinkia

Chemokines and their receptors have a multifaceted role in tumor biology and are implicated in nearly all aspects of cancer growth, survival and dissemination. Modulation of the interaction between chemokines and their cell surface receptor is, therefore, a promising area for the development of new cancer medicines. In this review, we look at the compelling evidence that is emerging to support targeting CXC chemokines, also known as family α chemokines, as novel therapeutic strategies in the treatment of cancer.


PLOS ONE | 2015

Study of the Chemotactic Response of Multicellular Spheroids in a Microfluidic Device

Jose M. Ayuso; Haneen A. Basheer; Rosa Monge; Pablo Sánchez-Álvarez; M. Doblaré; Steven D. Shnyder; Victoria Vinader; Kamyar Afarinkia; Luis J. Fernández; Ignacio Ochoa

We report the first application of a microfluidic device to observe chemotactic migration in multicellular spheroids. A microfluidic device was designed comprising a central microchamber and two lateral channels through which reagents can be introduced. Multicellular spheroids were embedded in collagen and introduced to the microchamber. A gradient of fetal bovine serum (FBS) was established across the central chamber by addition of growth media containing serum into one of the lateral channels. We observe that spheroids of oral squamous carcinoma cells OSC–19 invade collectively in the direction of the gradient of FBS. This invasion is more directional and aggressive than that observed for individual cells in the same experimental setup. In contrast to spheroids of OSC–19, U87-MG multicellular spheroids migrate as individual cells. A study of the exposure of spheroids to the chemoattractant shows that the rate of diffusion into the spheroid is slow and thus, the chemoattractant wave engulfs the spheroid before diffusing through it.


Journal of Pharmacological and Toxicological Methods | 2011

An agarose spot chemotaxis assay for chemokine receptor antagonists.

Victoria Vinader; Yousef Al-Saraireh; Helen L. Wiggins; Joshua Z. Rappoport; Steve D. Shnyder; Laurence H. Patterson; Kamyar Afarinkia

INTRODUCTION Chemokines are important players in directing the migration of cancer cells as part of the metastatic process. The aim of this study is to develop an easy-to-perform, reliable, and inexpensive assay for rapid analysis of anti-chemotactic activity of chemokine antagonists under a number of experimental conditions. METHODS An agarose spot containing the chemokine chemoattractant is applied to a glass petri dish. Live cells in a media, both with and without a chemokine antagonist, are added to the dish and, following cell adhesion, the migration under the agarose spot is observed and analysed by microscopy. RESULTS In the absence of CXCL12 in the agarose, no migration under the agarose spot is detected. In the presence of CXCL12, significant migration under the agarose spot is observed which can be retarded if a neutralising monoclonal antibody or a small molecule antagonist is added to the media. DISCUSSION This experimental configuration is a reliable, inexpensive and easy-to-perform chemotaxis assay, which enables assessment of the activity of CXCR4 antagonists.


PLOS ONE | 2013

Synthesis of a pseudo-disaccharide library and its application to the characterisation of the heparanase catalytic site.

Victoria Vinader; Mohamed H. Haji-Abdullahi; Laurence H. Patterson; Kamyar Afarinkia

A novel methodology is described for the efficient and divergent synthesis of pseudodisaccharides, molecules comprising of amino carbasugar analogues linked to natural sugars. The methodology is general and enables the introduction of diversity both at the carbasugar and the natural sugar components of the pseudodisaccharides. Using this approach, a series of pseudodisaccharides are synthesised that mimic the repeating backbone unit of heparan sulfate, and are tested for inhibition of heparanase, a disease-relevant enzyme that hydrolyses heparan sulfate. A new homology model of human heparanase is described based on a family 79 β-glucuronidase. This model is used to postulate a computational rationale for the observed activity of the different pseudodisaccharides and provide valuable information that informs the design of potential inhibitors of this enzyme.


Organic Letters | 2010

A synthesis of carbasugar-sugar pseudodisaccharides via a cycloaddition-cycloreversion reaction of 2H-pyran-2-ones.

Kamyar Afarinkia; Mohamed Haji Abdullahi; Ian J. Scowen

Cycloaddition of 3-carbomethoxy-2H-pyran-2-one to a vinylated sugar followed by the loss of bridging CO(2) from the cycloadduct affords a cyclohexadiene which can be manipulated to a carbasugar-sugar pseudodisaccharide.


PLOS ONE | 2013

Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.

Victoria Vinader; Djevdet S. Ahmet; Mohaned S.A. Ahmed; Laurence H. Patterson; Kamyar Afarinkia

Amongst the chemokine signalling axes involved in cancer, chemokine CXCL12 acting on chemokine receptor CXCR4 is particularly significant since it orchestrates migration of cancer cells in a tissue-specific metastatic process. High CXCR4 tumour expression is associated with poor prognosis of lung, brain, CNS, blood and breast cancers. We have identified a new class of small molecule CXCR4 antagonists based on the use of computational modelling studies in concert with experimental determination of in vitro activity against CXCL12-induced intracellular calcium mobilisation, proliferation and chemotaxis. Molecular modelling proved to be a useful tool in rationalising our observed potencies, as well as informing the direction of the synthetic efforts aimed at producing more potent compounds.


Organic Letters | 2009

A new, general method for the synthesis of carbasugar-sugar pseudodisaccharides.

Kamyar Afarinkia; Mohamed Haji Abdullahi; Ian J. Scowen

A general synthetic methodology for the synthesis of sugar-carbasugar pseudodisaccharides is described. The methodology is based on the cycloaddition of pyran-2-ones to vinylated sugars and the subsequent manipulation of the cycloadducts to construct the carbasugar component of the pseudodisaccharide.


MedChemComm | 2015

Probing cytochrome P450-mediated activation with a truncated azinomycin analogue

Victoria Vinader; Maria Sadiq; Mark Sutherland; Mengying Huang; Paul M. Loadman; Lina Elsalem; Steven D. Shnyder; Hongjuan Cui; Kamyar Afarinkia; Mark Searcey; Laurence H. Patterson; Klaus Pors

A deactivated alkene precursor (IC50 = 81 μM) to the azinomycin epoxide natural product can be bioactivated by several cytochromes P450 (CYP) to generate antiproliferative metabolites with increased potency (IC50 = 1–30 μM) in CHOwt cells. CYP1A1 and 3A4 were shown to generate exclusively the unnatural and the natural-configured azinomycin epoxide diastereoisomer respectively, while CYP1B1 produced both epoxides in a 3 : 1 mixture. The antiproliferative activity is linked to DNA damage as demonstrated using the comet assay.

Collaboration


Dive into the Kamyar Afarinkia's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiu-wan Yu

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge